Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry - PubMed (original) (raw)
. 1999 Nov 1;94(9):3094-100.
Affiliations
- PMID: 10556194
Free article
Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry
K Kuzushima et al. Blood. 1999.
Free article
Abstract
We have developed an efficient and rapid method for detection of Epstein-Barr virus (EBV)-specific CD8(+) T-cell frequencies both in freshly isolated peripheral blood mononuclear cells (PBMCs) and in vitro established cytotoxic T lymphocyte (CTL) lines. Responder cells are thereby stimulated with an autologous lymphoblastoid cell line for 5 hours and intracellular accumulation of interferon gamma (IFNgamma) is detected by multiparameter flow cytometric analysis. EBV-specific CD8(+) T-cell frequencies ranged between 0.63% and 1. 29% in PBMCs of 5 healthy long-term EBV carriers. Using EBV-specific T-cell lines, it was shown that flow cytometric analysis is more sensitive than limiting dilution analysis for CTL precursors and enzyme-linked immunospot assay detecting IFNgamma-producing T cells. The class I restriction of IFNgamma production was confirmed using an anti-class I monoclonal antibody (MoAb). Information on other cytokine production of EBV-specific CTLs could be obtained using combinations of anti-cytokine MoAbs. The sensitive and rapid nature of the flow cytometric assay for EBV-specific CD8(+) T-cell frequency has significant advantages for evaluation of EBV-specific CD8(+) T-cell responses in PBMCs of patients with EBV-related diseases.
Similar articles
- Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.
Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG, Dupont B, O'Reilly RJ. Koehne G, et al. Blood. 2002 Mar 1;99(5):1730-40. doi: 10.1182/blood.v99.5.1730. Blood. 2002. PMID: 11861290 - Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ. Vogl BA, et al. J Med Virol. 2012 Jan;84(1):119-31. doi: 10.1002/jmv.22258. J Med Virol. 2012. PMID: 22095540 - Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens.
Yang J, Lemas VM, Flinn IW, Krone C, Ambinder RF. Yang J, et al. Blood. 2000 Jan 1;95(1):241-8. Blood. 2000. PMID: 10607708 - Routine detection of Epstein-Barr virus specific T-cells in the peripheral blood by flow cytometry.
Crucian BE, Stowe RP, Pierson DL, Sams CF. Crucian BE, et al. J Immunol Methods. 2001 Jan 1;247(1-2):35-47. doi: 10.1016/s0022-1759(00)00326-4. J Immunol Methods. 2001. PMID: 11150535 - Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
Metes D, Storkus W, Zeevi A, Patterson K, Logar A, Rowe D, Nalesnik MA, Fung JJ, Rao AS. Metes D, et al. Transplantation. 2000 Nov 27;70(10):1507-15. doi: 10.1097/00007890-200011270-00019. Transplantation. 2000. PMID: 11118098
Cited by
- Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K. Demachi-Okamura A, et al. Cancer Sci. 2008 Aug;99(8):1633-42. doi: 10.1111/j.1349-7006.2008.00852.x. Cancer Sci. 2008. PMID: 18754877 Free PMC article. - Differentiation of human alloreactive CD8(+) T cells in vitro.
Rentenaar RJ, Vosters JL, van Diepen FN, Remmerswaal EB, van Lier RA, ten Berge IJ. Rentenaar RJ, et al. Immunology. 2002 Mar;105(3):278-85. doi: 10.1046/j.0019-2805.2002.01374.x. Immunology. 2002. PMID: 11918689 Free PMC article. - Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.
Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, Delarosa C, Disis ML. Maecker HT, et al. BMC Immunol. 2008 Mar 17;9:9. doi: 10.1186/1471-2172-9-9. BMC Immunol. 2008. PMID: 18366814 Free PMC article. - Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S, Ito Y, Gotoh K, Kojima S, Matsumoto K, Kinoshita T, Iwata S, Nishiyama Y, Kimura H. Kawabe S, et al. Cancer Sci. 2012 Aug;103(8):1481-8. doi: 10.1111/j.1349-7006.2012.02305.x. Epub 2012 May 15. Cancer Sci. 2012. PMID: 22497716 Free PMC article. - Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.
Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Hislop AD, et al. J Exp Med. 2002 Apr 1;195(7):893-905. doi: 10.1084/jem.20011692. J Exp Med. 2002. PMID: 11927633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials